A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-Small Cell Lung Cancer
A Single-Arm, Open-Label, Interventional Study to Evaluate the Efficacy of HS-IT101 Autologous Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy After Lymphodepleting Preconditioning with Fludarabine and Cyclophosphamide and Subsequent Interleukin-2 Therapy in Patients with Advanced Non-Small Cell Lung Cancer.
Age 18 to 75 years; [+9]
Patients with a history of severe hypersensitivity reactions to any drug used du... [+16]